The proposed concept of hemaPEN® is a novel blood collection and dispensing platform in dried blood spot (DBS) format. It integrates end-to-end capillary with pre-punched DBS paper for blood collection and dispensing. It exemplifies the advantages of DBS micro-sample stability, while addressing the associated limitations of volumetric accuracy, hematocrit effect and sample integrity.
The proposed concept of the hemaPEN platform technology is expected to provide easy, and more convenient sampling process for dried blood spot (DBS) collection.
hemaPEN has the potential to redefine blood collection, storage and transport, and improve access to near-patient sampling. Initial results demonstrate the capillary collection method in hemaPEN provides a high level of precision compared to other dispensing methods.
The capillary collection mechanism dispenses an accurate volume of blood onto specialized, approved filter paper. The integrated compartments protect collected samples at every stage of the process. Following blood collection, the device can then be sent via regular mail to the laboratory for analysis.
It is possible that the hemaPEN will be used by both healthcare and non-healthcare professionals. Its adoption into current healthcare systems may save time, reduce healthcare costs, and improve accuracy of blood analysis.
Enhanced user experience
The hemaPEN® is in development and is for investigational use only. Not available for sale.